Antibiotic Recalled

Ascend Laboratories is voluntarily recalling approximately 4000 bottles of cefixime capsules for failing to meet impurity/degradation specifications, according to the November 17, 2021, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects 50-count bottles of cefixime capsules, 400 mg (NDC 67877-584-50), from lot 20140282 (Exp. 12/21). The capsules were manufactured by Alken Laboratories, Mumbai, India, and distributed by Ascend Laboratories, Parsippany, NJ, throughout the United States.

Ascend Laboratories initiated the recall November 3, 2021. The FDA designated the recall Class II on November 9, 2021. The designation communicates that use of the affected product could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists.

Cefixime is a prescription antibiotic used to treat a variety of bacterial infections.